Stocktoria
FITLIFE BRANDS, INC. FTLF
Nasdaq · XNAS · stock · Medicinal Chemicals & Botanical Products · website · IPO 2007-10-26
FITLIFE BRANDS, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 43.1% | 43.6% | 40.7% | 41.8% | 44.8% |
| Operating margin | 18.6% | 20.3% | 14.3% | 19.8% | 22.3% |
| Net margin | 12.7% | 13.9% | 10.0% | 15.4% | 19.4% |
| FCF margin | 46.4% | 14.9% | 7.8% | 14.3% | — |
| Return on assets | 1.9% | 15.3% | 9.6% | 17.2% | 25.2% |
| Return on equity | 4.6% | 24.9% | 19.6% | 20.7% | 31.2% |
| Debt / equity | — | 0.36× | 0.74× | 0.00× | — |
| Current ratio | 1.53 | 1.60 | 1.42 | 5.43 | 4.36 |
| Revenue growth | -75.3% | 22.3% | 83.0% | 3.2% | 26.2% |
Source: SEC EDGAR filings · CIK 0001374328 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.